Health Care
Canopy Growth accelerates US expansion plans with AgriNextUSA acquisition
The world’s largest cannabis company by market cap, Canopy Growth Corporation (CGC), on Thursday said it was acquiring US-based hemp…
What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards this liver…
Aurinia’s loss widened to $14.6 million in Q4 2018
Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) reported its fourth quarter and full-year 2018 results after the bell today. The company reported…
Catalyst Pharma loss widens in Q4 due to Firdapse launch
Catalyst Pharmaceuticals (Nasdaq: CPRX) reported a loss of $0.14 per share compared to $0.12 loss expected by the street. The…
Dermira stock doubles and hits new 52-week high on positive eczema trial results
Dermira Inc. (DERM) announced positive results from Phase 2b study for treating patients with atopic dermatitis, a condition which causes…
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month…
NASH drug developer Genfit plans $132-million US IPO, to list on Nasdaq
France-based biopharmaceutical firm Genfit (EPA: GNFT) has launched a global offering of its American Depository Shares and ordinary shares to…